1-Dec-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Medicine
Oncology
Top 10s
Oncology
Current Top 10 by F1000 Factor
All Time Top 10 by F1000 Factor
Most viewed Top 10
(from all journals)
Most viewed Top 10
(from specialty journals)
Hidden Jewels
Sections Covered
Breast Diseases: Benign & Malignant
Cancer in the Elderly
Genitourinary Cancers
Gynecological Cancers
Head & Neck Cancers
Oncology Agents
Pediatric Oncology
Sarcomas
Supportive & Palliative Cancer Care
Related Sections
Adrenal Cortex
Gastrointestinal Cancers
Leukemia & Proliferative Disorders of Hematic Cells
Lung Cancer
Lymphomas & Myelomas
Multiple Endocrine Disorders & Neoplasias
Neuro-Oncology
Skin Cancers (inc. Melanoma & Lymphoma)
MOST VIEWED TOP 10 (from specialty journals) | Oncology | calculated on 1 December 2008
The "Most Viewed Top 10 (from specialty journals)" Top 10 lists are generated every day and comprise only articles published in specialty journals. The articles are ordered by the number of times an article's evaluation(s) has/have been viewed over the past 30 days. The general journals that are excluded from this list are;
Ama Arch Intern Med, Ann Intern Med, BMJ, Cell, CMAJ, J Clin Invest, JAMA, Lancet, N Engl J Med, Nat Med, Nature, Science.
browse faculty
| show Most Viewed (specialty journals) Papers in
ALL OF MEDICINE
Anesthesiology & Pain Management
Cardiovascular Disorders
Critical Care & Emergency Medicine
Dermatology
Diabetes & Endocrinology
Gastroenterology & Hepatology
Hematology
Infectious Diseases
Nephrology
Neurological Disorders
Oncology
Psychiatry
Public Health & Epidemiology
Research Methodology
Respiratory Disorders
Rheumatology & Clinical Immunology
Urology
Women's Health
selected articles
all 10 items
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
1
Must Read
F1000 Factor
6.0
Changes
Clinical Practice
Tech Advance
Chemotherapy for colorectal cancer liver metastases.
Alberts SR, Wagman LD
Oncologist
2008 Oct
13
(10):1063-73 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Gilberto Schwartsmann with Fabio Leal
Evaluated 10 Nov 2008
2
Must Read
F1000 Factor
4.8
New Finding
Tech Advance
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Wiernik PH, Lossos IS, …, Zeldis JB, Habermann TM
J Clin Oncol
2008 Oct 20
26
(30):4952-7 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Asher Chanan-Khan with Sikander Ailawadhi / Allessandro Gianni with Michele Magni
First evaluation 7 Nov 2008 | Latest evaluation 19 Nov 2008
3
Recommended
F1000 Factor
3.0
Hypothesis
New Finding
Controversial
Detection and characterization of CD133+ cancer stem cells in human solid tumours.
Tirino V, Desiderio V, …, De Rosa A, Papaccio G
PLoS ONE
2008
3
(10):e3469 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Stephen Lessnick
Evaluated 3 Nov 2008
4
Must Read
F1000 Factor
6.0
Hypothesis
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells.
Taussig DC, Miraki-Moud F, …, Gribben JG, Bonnet D
Blood
2008 Aug 1
112
(3):568-75 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Zhu Chen
Evaluated 25 Sep 2008
5
Must Read
F1000 Factor
6.0
Changes
Clinical Practice
Confirmation
New Finding
A Manual of Guidelines to Score the Modified Cumulative Illness Rating Scale and Its Validation in Acute Hospitalized Elderly Patients.
Salvi F, Miller MD, …, Rappelli A, Dessì-Fulgheri P
J Am Geriatr Soc
2008 Sep 22
56
[
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Lazzaro Repetto
Evaluated 17 Oct 2008
6
Recommended
F1000 Factor
3.0
Hypothesis
New Finding
Tech Advance
Controversial
EWS-FLI1 Induces Developmental Abnormalities and Accelerates Sarcoma Formation in a Transgenic Mouse Model.
Lin PP, Pandey MK, …, Parant JM, Lozano G
Cancer Res
2008 Nov 1
68
(21):8968-75 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Stephen Lessnick
Evaluated 5 Nov 2008
7
Must Read
F1000 Factor
6.0
Confirmation
New Finding
Improved survival in patients with Stage III-IV Head and neck cancer treated with radiotherapy as primary local treatment modality.
Rusthoven KE, Raben D, Chen C
Int J Radiat Oncol Biol Phys
2008 Oct 1
72
(2):343-50 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Mauro Palazzi
Evaluated 29 Oct 2008
8
Must Read
F1000 Factor
6.0
Confirmation
Residual prostate cancer after radiotherapy: a study of radical cystoprostatectomy specimens.
Kaplan DJ, Crispen PL, …, Horwitz EM, Uzzo RG
Urology
2008 Sep
72
(3):654-8 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Juan Palou Redorta with Guillermo Urdaneta Pignalosa
Evaluated 31 Oct 2008
9
Must Read
F1000 Factor
4.8
Confirmation
New Finding
Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
Robinson KS, Williams ME, …, Lemieux B, Cheson BD
J Clin Oncol
2008 Sep 20
26
(27):4473-9 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Kensei Tobinai / Allessandro Gianni with Michele Magni
First evaluation 24 Sep 2008 | Latest evaluation 21 Oct 2008
10
Must Read
F1000 Factor
6.0
Confirmation
New Finding
Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
Köllermann J, Weikert S, …, Rau T, Pantel K
J Clin Oncol
2008 Oct 20
26
(30):4928-33 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Charles Ryan
Evaluated 4 Nov 2008
© 2008 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info
Tech Advance
New Finding
Hypothesis
Controversial
Confirmation